Plasmid DNA—The Versatile Building Block
Plasmid DNA (pDNA) is a critical raw material for the manufacture of cell and gene therapies. As this market continues to grow, so too does the demand for high-quality pDNA.
Navigating the Intricacies of Lentiviral CGTs
Scientists are leveraging ddPCR technology to get an accurate read on viral titer and vector copy number.
A Growing Biologics Market
As more novel therapy approvals trend towards biologics, it is important to take stock of what treatments are shaping the future of the market.
Protecting Biologics at Every Turn
Cold chain stakeholders continue to innovate with new technology development, the use of advanced modeling and analytics capabilities, and the pursuit of strategic partnerships.
Logistical Considerations in mRNA Vaccine Development
Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.
